Colinz Laboratories

Colinz Laboratories Assets per Share

The Total Assets per Share of Colinz Laboratories (531210.BO) as of Oct 15, 2026 is 50.72 INR. In the previous year, Total Assets per Share was 46.89 INR — a change of 8.16% (higher).

Assets per Share

50.72INR

YoY

8.16%

Last updated:

Total Assets per Share of Colinz Laboratories is 2026 50.72 INR. Total Assets per Share of Colinz Laboratories was 2025 46.89 INR. It decreases by 8.16% higher compared to the previous year.

The Colinz Laboratories Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2019
36.41 INR
Jan 1, 2020
34.96 INR
Jan 1, 2021
40.09 INR
Jan 1, 2022
39.41 INR
Jan 1, 2023
40.60 INR
Jan 1, 2024
45.08 INR
Jan 1, 2025
46.89 INR
Jan 1, 2026
50.72 INR
The Colinz Laboratories Assets per Share history
YEARAssets per ShareYoY
50.72INR+8.16%
46.89INR+4.03%
45.08INR+11.03%
40.60INR+3.01%
39.41INR-1.69%
40.09INR+14.66%
34.96INR-3.97%
36.41INR-4.33%
38.06INR-0.88%
38.39INR-0.99%
38.78INR-8.30%
42.29INR+6.65%
39.65INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Colinz Laboratories Stock analysis

What does Colinz Laboratories do? Colinz Laboratories Ltd, listed on the Bombay Stock Exchange with ticker 531210.BO and ISIN INE923C01011, is a pharmaceutical company headquartered in Mumbai, India. The company operates within the Health Care sector, specifically in the Pharmaceuticals industry. It went public through an IPO on January 13, 2004. Colinz Laboratories is engaged in the manufacturing and marketing of pharmaceutical formulations across various dosage forms, including tablets, capsules, granules, liquid orals, injectables, ointments, and creams. The company's product portfolio targets several medical conditions, such as hypertension, cholesterol, diabetes, piles, pyrexia, and malaria, with specific offerings for gynecological treatments like morning sickness, infertility, intrauterine growth restriction (IUGR), and pregnancy maintenance. Additionally, it provides hematinic, antispasmodic, anti-inflammatory, anti-allergic, and medicated shampoo products. Colinz Laboratories markets its products directly within several Indian states, including Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh, and West Bengal, utilizing its own marketing team. The company's website is www.colinz.com. It is important to note that the company's operations and product details are based on the provided information without additional verification. Colinz Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Colinz Laboratories stock

Total Assets per Share of Colinz Laboratories is 50.72 INR in 2026.

Total Assets per Share of Colinz Laboratories changed from 46.89 INR to 50.72 INR, representing a 8.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Colinz Laboratories since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — Colinz Laboratories

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — Colinz Laboratories